Jiuqiang Biotech announced that due to the fact that the fifth restricted stock incentive plan was granted a second company-level performance assessment during the lifting of sales restrictions, the company completed partial restricted stock repurchase cancellation on July 23, 2026, involving 7 people, totaling 168,162 shares, accounting for 0.03% of the total share capital before cancellation, and paid a repurchase price of 1.3638 million yuan. After the cancellation was completed, the total share capital of the company was reduced to 586,140,466 shares. Due to the small proportion of shares repurchased and cancelled, the conversion price of the “Top Nine Convertible Bonds” is still 11.60 yuan/share. The cancellation of shares had no substantial impact on the company's finances and operations.

Jiuqiang Biotech announced that due to the fact that the fifth restricted stock incentive plan was granted a second company-level performance assessment during the lifting of sales restrictions, the company completed partial restricted stock repurchase cancellation on July 23, 2026, involving 7 people, totaling 168,162 shares, accounting for 0.03% of the total share capital before cancellation, and paid a repurchase price of 1.3638 million yuan. After the cancellation was completed, the total share capital of the company was reduced to 586,140,466 shares. Due to the small proportion of shares repurchased and cancelled, the conversion price of the “Top Nine Convertible Bonds” is still 11.60 yuan/share. The cancellation of shares had no substantial impact on the company's finances and operations.